- QMRO Home
- William Harvey Research Institute
- Centre for Biochemical Pharmacology
- Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice
Browse
Administrators only